Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Use this BBNX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BBNX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BBNX SEC filings page. Lician reads the product cache first so this HTML stays unique to Beta Bionics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full BBNX income, balance, and cash tables.